News

The new company’s product portfolio comprises medicines targeting treatment of inflammatory diseases and conditions including atopic dermatitis, dry eye syndrome, interstitial cystitis, and lymphatic disorders, as well as

The study results demonstrated that the addition of Cimzia to current therapy showed rapid and consistent efficacy across the patients taking certolizumab pegol whether they had previously received

The study is a placebo-controlled, double-blinded, single site Phase I trial which involves 24 healthy women randomized in two groups to monitor the safety and immunogenicity of the

The company expects to disclose the results within eight weeks. Heplisav is an experimental adult hepatitis B vaccine which is evaluated in two Phase 3 studies that are

With this agreement, PharmaNet will have to access potential subjects who are suffering from mild, moderate, or severe impaired renal function. PharmaNet Early Stage Development president Riaz Bandali

In 2002, Amylin had entered into an alliance with Lilly for the global development and commercialization of exenatide, a medicine indicated as a first line treatment for type

Genmed focuses on the delivery of low cost generic pharmaceutical drugs directly to distribution channels. Genmed said prior to the approval it was already approved to distribute 20

Vayacog, a once-daily formulation of phosphatidylserine – omega 3 compound, DHA enriched, is a prescription medical food. Regulated by the US Food and Drug Administration under the Orphan

The approval has been granted for Sativex as an add-on therapy to treat moderate to severe spasticity due to multiple sclerosis (MS) in patients who have not responded